Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

CMRC vs. CHWY: Which Stock Is the Better Value Option?
CMRC vs. CHWY: Which Stock Is the Better Value Option?

Investors interested in stocks from the Internet - Commerce sector have probably already heard of Commerce.com (CMRC) and Chewy (CHWY). But which of these two stocks presents investors with the

HCMLY or IBP: Which Is the Better Value Stock Right Now?
HCMLY or IBP: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Building Products - Miscellaneous sector might want to consider either Holcim Ltd Unsponsored ADR (HCMLY) or Installed Building Products (IBP). But which of these

OMRNY vs. VPG: Which Stock Is the Better Value Option?
OMRNY vs. VPG: Which Stock Is the Better Value Option?

Investors with an interest in Electronics - Miscellaneous Components stocks have likely encountered both Omron Corp. (OMRNY) and Vishay Precision (VPG). But which of these two stocks presents

BWA or OPLN: Which Is the Better Value Stock Right Now?
BWA or OPLN: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Automotive - Original Equipment sector have probably already heard of BorgWarner (BWA) and OPENLANE (OPLN). But which of these two companies is the best

STRA or UTI: Which Is the Better Value Stock Right Now?
STRA or UTI: Which Is the Better Value Stock Right Now?

Investors interested in Schools stocks are likely familiar with Strategic Education (STRA) and Universal Technical Institute (UTI). But which of these two stocks presents investors with the better

Amprius Stock Is Flashing One Signal That Traders Rarely Ignore
Amprius Stock Is Flashing One Signal That Traders Rarely Ignore

Amprius (NYSE: AMPX) stock price is likely to move higher, much higher, because its technical signals, driven by a robust fundamental outlook, converge with the single signal that counts: trading

Barclays Stock Dips 14.1% YTD: Is It a Buy After the Recent Pullback?
Barclays Stock Dips 14.1% YTD: Is It a Buy After the Recent Pullback?

Shares of Barclays PLC BCS on NYSE have declined 14.1% year to date, compared with a 1.8% drop of the industry and a 1.9% fall of the S&P 500 Index. Among its peers, Deutsche Bank DB shares have

HL Surges 85.9% in 6 Months: Here's How to Play the Stock
HL Surges 85.9% in 6 Months: Here's How to Play the Stock

Hecla Mining Company’s HL shares have surged 85.9% in the past six months, underperforming the industry and outperforming the S&P 500, which have returned 93.9% and 4.1%, respectively. In

Pre-Markets in the Red as Geopolitical Tensions Escalate
Pre-Markets in the Red as Geopolitical Tensions Escalate

“May you live in interesting times,” goes the ancient curse. We start a new week of stock market challenges sinking again in the pre-market. The ongoing war in Iran is now in its second week with no

Healthcare Jobs Drop, UnitedHealth Stock Slips: Opportunity or Risk?
Healthcare Jobs Drop, UnitedHealth Stock Slips: Opportunity or Risk?

UnitedHealth Group Incorporated UNH continues to go through a turbulent phase while navigating rising medical costs, regulatory scrutiny and shifting industry dynamics. For investors accustomed to

LMT Stock Surges 43.6% in 3 Month: Time to Hold or Book Profits?
LMT Stock Surges 43.6% in 3 Month: Time to Hold or Book Profits?

Lockheed Martin’s LMT shares have risen 43.6% in the past three months, outperforming the Zacks Aerospace-Defense industry’s growth of 12.3%. Lockheed Martin is one of the largest U.S. defense

Are Tech ETFs New Safe Haven Amid Iran War?
Are Tech ETFs New Safe Haven Amid Iran War?

Global markets remained under pressure last week as escalating U.S.–Israel strikes on Iran pushed oil prices to their highest levels since 2024 (as quoted on Yahoo Finance), forcing investors to

Shell ETF (SHEH) Touches Fresh 52-Week High
Shell ETF (SHEH) Touches Fresh 52-Week High

For investors seeking momentum, Shell plc – ADRhedged SHEH is probably on the radar now. The fund just hit a 52-week high and is up 42.2% from its 52-week low price of $43.91 per share.

But are more

Is the Options Market Predicting a Spike in ING Group Stock?
Is the Options Market Predicting a Spike in ING Group Stock?

Investors in ING Group, Inc. ING need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $25.00 Call had some of the highest implied

Rocket Lab Gains 21.9% in the Past 3 Months: Should You Buy?
Rocket Lab Gains 21.9% in the Past 3 Months: Should You Buy?

Rocket Lab Corporation RKLB stock has surged 21.9% in the past three months, surpassing the 15.8% growth of the Zacks Aerospace-Defense Equipment industry. It has also outperformed the Zacks Aerospa

Are Options Traders Betting on a Big Move in Prosperity Bancshares Stock?
Are Options Traders Betting on a Big Move in Prosperity Bancshares Stock?

Investors in Prosperity Bancshares, Inc. PB need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $60.00 Call had some of the highest

GE Gains From Strength in Commercial Engines: Can the Momentum Sustain?
GE Gains From Strength in Commercial Engines: Can the Momentum Sustain?

GE Aerospace GE is witnessing strong momentum in the Commercial Engines & Services segment. Organic revenues from the segment increased 24% year over year in the fourth quarter of 2025, constituting

EMCOR Stock Slides 12% Post Q4 Results: Buy the Dip or Wait?
EMCOR Stock Slides 12% Post Q4 Results: Buy the Dip or Wait?

EMCOR Group, Inc. EME tumbled 12% since reporting its fourth-quarter 2025 earnings performance, underperforming the Zacks Building Products - Heavy Construction industry, but outperforming the

Are Emerging Markets Key to Coca-Cola's Long-Term Revenue Growth?
Are Emerging Markets Key to Coca-Cola's Long-Term Revenue Growth?

The Coca-Cola Company’s KO emerging markets form a critical pillar of long-term revenue growth. Such markets are vital for growth as they offer a stronger population, rising beverage consumption and

Should You Buy, Sell, or Hold UiPath Stock Before Q4 Earnings?
Should You Buy, Sell, or Hold UiPath Stock Before Q4 Earnings?

UiPath Inc. PATH will report its fourth-quarter fiscal 2026 results on March 11, after the bell.

The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at 25 cents

Is Roku Stock a Buy as Platform Revenues and ARPU Improve?
Is Roku Stock a Buy as Platform Revenues and ARPU Improve?

Roku, Inc. ROKU is gaining investor attention as its platform monetization strategy begins to deliver measurable financial results. The streaming platform's fourth-quarter 2025 earnings offered

Implied Volatility Surging for Intercontinental Exchange Stock Options
Implied Volatility Surging for Intercontinental Exchange Stock Options

Investors in Intercontinental Exchange, Inc. ICE need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $85.00 Put had some of the

Key Reasons to Add Cousins Properties to Your Portfolio Now
Key Reasons to Add Cousins Properties to Your Portfolio Now

Cousins Properties’ CUZ portfolio of Class A office assets in high-growth Sun Belt markets is witnessing higher leasing activity due to tenants’ preference for premium office spaces with class-apart

Oracle's AI Push: A Potential Catalyst for Q3 Earnings Growth?
Oracle's AI Push: A Potential Catalyst for Q3 Earnings Growth?

Oracle Corporation ORCL is set to report third-quarter fiscal 2026 results on March 10, 2026, covering the period from December 2025 through February 2026. Non-GAAP earnings per share are expected

Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study
Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study

Roche RHHBY announced results from a late-stage study evaluating its investigational candidate, giredestrant, in combination with palbociclib for patients with estrogen receptor (ER)-positive, human